Human Microbiome Market to Reach US$ 1,197.08 Million at CAGR of 21.8% by 2025 | The Insight Partners

Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Geography

Publication Month: Jan 2019 | Report Code: TIPBT00002233 | No. of Pages: 163 | Category: Biotechnology | Status: Published

The global human microbiome market accounted to US$ 257.30 Mn in 2017 and is expected to grow at a CAGR of 21.8% during the forecast period 2018 - 2025, to account to US$ 1,197.08 Mn by 2025.

 

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven by the factors such as, increasing focus on development of microbiome therapeutics and conferences in this region

 

Exhibit: Lucrative Regional Markets


 

Market Insights

Increasing Incidence of Lifestyle Diseases

Over the past few decades, human microbiome is related to lifestyle diseases like cancer, diabetes, obesity, depression and many others. Changes in lifestyles and societal norms influence the microbiome at each stage of life. Altering the human microbiome can help in eliminating such lifestyle diseases. As per World health organization in 2016, 13% of the world population (adults) were obese. According to the “The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation” published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), which involves the transfer of feces from a healthy donor to the patient, is a potential treatment for obesity

 

Growing Technological Advancements in Metagenomics and Next-generation Sequencing

 

Technological advancements in metagenomics and next-generation sequencing have made microbiome-based testing easier and cheaper, and have led to rapid analysis of the genomic content of microorganisms from human sample. This has bolstered the development process for microbiome-based diagnostics. Gastrointestinal and metabolic disorders are likely to capture the leading share of the diagnostics market in 2018 owing to rise in interest of companies toward developing an easy analysis platform for gut health-based disorders, such as irritable bowel syndrome and Crohn’s disease. Although cancer is likely to capture a minor share of the market in 2018, much lower than gut health and metabolic disorders, it is a niche operating area for the company involved in developing a diagnostic test for detecting cancer. For instance, Metabiomics is developing molecular diagnostics for detecting markers of colorectal cancer. Existing tests for colorectal cancer rely on invasive colonoscopies; and thus, the non-invasive test developed by Metabiomics (which uses a stool sample to evaluate patient’s gut microbiome) will be a unique opportunity for the company to excel in a market having huge unmet needs.

 

Product Insights

The global human microbiome market by product was led by probiotics segment. In 2017, the probiotics segment held a largest market share of 24.7% of the human microbiome market, by product. The probiotics segment is expected to dominate the market in 2025, due to increasing health concerns, growing awareness regarding the relation of nutrition, diet, and health, and increasing probiotics market penetration in dairy and other food and beverages industry is expected to favor the overall demand.

 

Disease Insights

The human microbiome market by disease was segmented into diabetes, cancer, autoimmune disorders, obesity, mental disorders and other diseases. The obesity segment held the largest share of the market, by disease. The segment is also likely to dominate in the forecast period, due to increase in the cases of obesity, caused due to various factors such as, lifestyle changes, sedentary lifestyle as well as unhealthy eating habits.

 

Application Insights

The human microbiome market by application was segmented into diagnostics and therapeutics. The therapeutics segment held the largest share of the market, by application. The segment is also anticipated to grow at a steady rate during the forecast period, owing to the increase in digestive problems, increase in the drug-related side effects.

 

Exhibit: Human Microbiome Market, by Application


 

Strategic Insights

Expansion and patent and license approvals were observed as the most adopted strategy in global human microbiome industry. Few of the recent expansions and license as well as patent approvals made by the players are listed below:

 

2018: In April, 2018, MicroBiome Therapeutics, LLC (MBT), announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy gastrointestinal (GI) microbiome.

2017: In June, 2017, Guangzhou Yakult Co., Ltd. in Guangdong Province, China, would start constructing the Foshan Plant in Foshan, Guangdong Province in July 2017 for production of the Yakult and Yakult Light.

 

HUMAN MICROBIOME - MARKET SEGMENTATION

 

By Product

  • Probiotics
  • Foods
  • Prebiotics
  • Medical Foods
  • Diagnostic Device
  • Drugs
  • Supplements

 

By Disease

  • Obesity
  • Diabetes
  • Autoimmune Disorders
  • Cancer
  • Mental Disorders
  • Others

 

By Application

  • Therapeutics
  • Diagnostics

 

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil

Company Profiles

  • Enterome
  • MicroBiome Therapeutics, LLC
  • Rebiotix Inc.
  • Yakult Honsha Co., Ltd.
  • Osel Inc.
  • Vedanta Biosciences, Inc.
  • Metabiomics Corporate
  • Synthetic Biologics, Inc.
  • DuPont
  • BiomX Ltd.

 

TABLE OF CONTENTS

1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. GLOBAL HUMAN MICROBIOME MARKET – KEY TAKEAWAYS

3. GLOBAL HUMAN MICROBIOME MARKET – MARKET LANDSCAPE
3.1 OVERVIEW
3.2 MARKET SEGMENTATION
3.2.1 Global Human Microbiome Market – By Product
3.2.2 Global Human Microbiome Market – By Disease
3.2.3 Global Human Microbiome Market – By Application
3.2.4 Global Human Microbiome Market – By Geography
3.3 PEST ANALYSIS
3.3.1 North America – PEST Analysis
3.3.2 Europe– PEST Analysis
3.3.3 Asia Pacific– PEST Analysis
3.3.4 Middle East And Africa– PEST Analysis
3.3.5 South and Central America – PEST Analysis

4. GLOBAL HUMAN MICROBIOME MARKET – KEY MARKET DYNAMICS
4.1 KEY MARKET DRIVERS
4.1.1 Increasing Incidence of Lifestyle Diseases
4.1.2 Increasing Focus On Human Microbiome Therapies
4.1.3 Growing Technological Advancements in Metagenomics and Next-generation Sequencing
4.2 KEY MARKET RESTRAINTS
4.2.1 Stringent Government Regulations
4.2.2 Lack of Knowledge Limiting the Growth of Market
4.3 KEY MARKET OPPORTUNITIES
4.3.1 New Drug Requirements for Faecal Microbiota
4.3.2 Emerging Nations
4.4 FUTURE TRENDS
4.4.1 The Human Microbiome - A New Frontier in Drug Discovery
4.5 IMPACT ANALYSIS

5. HUMAN MICROBIOME MARKET – GLOBAL ANALYSIS
5.1 GLOBAL HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS
5.2 GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS
5.3 MARKET POSITIONING
5.4 PERFORMANCE OF KEY PLAYERS
5.4.1 Enterome
5.4.2 Yakult Honsha Co., Ltd.
5.5 EXPERT OPINIONS

6. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS – BY PRODUCT
6.1 OVERVIEW
6.2 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
6.3 FOODS MARKET
6.3.1 Overview
6.3.2 Global Foods Market Revenue and Forecasts to 2025 (US$ Mn)
6.4 MEDICAL FOOD MARKET
6.4.1 Overview
6.4.2 Global Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 PROBIOTICS MARKET
6.5.1 Overview
6.5.2 Global Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 PREBIOTICS MARKET
6.6.1 Overview
6.6.2 Global Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 DRUGS MARKET
6.7.1 Overview
6.7.2 Global Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 DIAGNOSTIC DEVICES MARKET
6.8.1 Overview
6.8.2 Global Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)
6.9 SUPPLEMENTS MARKET
6.9.1 Overview
6.9.2 Global Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

7. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS – BY DISEASE
7.1 OVERVIEW
7.2 GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)
7.3 DIABETES MARKET
7.3.1 Overview
7.3.2 Global Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)
7.4 CANCER MARKET
7.4.1 Overview
7.4.2 Global Cancer Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 AUTOIMMUNE DISORDERS MARKET
7.5.1 Overview
7.5.2 Global Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 OBESITY MARKET
7.6.1 Overview
7.6.2 Global Obesity Market Revenue and Forecasts to 2025 (US$ Mn)
7.7 MENTAL DISORDERS MARKET
7.7.1 Overview
7.7.2 Global Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)
7.8 OTHERS MARKET
7.8.1 Overview
7.8.2 Global Others Market Revenue and Forecasts to 2025 (US$ Mn)

8. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS – BY APPLICATION
8.1 OVERVIEW
8.2 GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)
8.3 DIAGNOSTICS MARKET
8.3.1 Overview
8.3.2 Global Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.4 THERAPEUTICS MARKET
8.4.1 Overview
8.4.2 Global Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

9. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
9.1 OVERVIEW
9.2 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.3 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
9.4 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
9.5 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
9.6 NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
9.7 US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.7.1 US Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.7.2 US Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.7.3 US Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.7.4 US Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.8 CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.8.1 Canada Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.8.2 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.8.3 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.8.4 Canada Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
9.9 MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
9.9.1 Mexico Human microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
9.9.2 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
9.9.3 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
9.9.4 Mexico Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
10.1 OVERVIEW
10.2 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.3 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
10.4 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
10.5 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
10.6 EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
10.7 UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.7.1 UK Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
10.7.2 UK Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
10.7.3 UK Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
10.7.4 UK Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.8 GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.8.1 Germany Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
10.8.2 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
10.8.3 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
10.8.4 Germany Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.9 FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
10.9.1 France Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
10.9.2 France Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
10.9.3 France Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
10.9.4 France Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

11. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
11.1 OVERVIEW
11.2 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
11.4 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
11.5 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
11.6 ASIA PACIFIC GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
11.7 CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
11.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
11.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
11.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
11.8 JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
11.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
11.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
11.8.4 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
11.9 INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
11.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
11.9.2 India Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
11.9.3 India Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
11.9.4 India Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

12. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025
12.1 OVERVIEW
12.2 MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.3 MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
12.4 MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
12.5 MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
12.6 MIDDLE EAST AND AFRICA AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
12.7 UAE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.7.1 UAE Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
12.7.2 UAE Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
12.7.3 UAE Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
12.7.4 UAE Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
12.8 SAUDI ARABIA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.8.1 Saudi Arabia Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
12.8.2 Saudi Arabia Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
12.8.3 Saudi Arabia Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
12.8.4 Saudi Arabia Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)
12.9 SOUTH AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
12.9.1 South Africa Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
12.9.2 South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
12.9.3 South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
12.9.4 South Africa Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

13. SOUTH AND CENTRAL AMERICA EPIGENTICS MARKET REVENUE AND FORECASTS TO 2025
13.1 OVERVIEW
13.2 SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
13.3 SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
13.4 SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
13.5 SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
13.6 SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
13.7 BRAZIL HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
13.7.1 Brazil Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)
13.7.2 Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)
13.7.3 Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)
13.7.4 Brazil Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

14. HUMAN MICROBIOME MARKET –INDUSTRY LANDSCAPE
14.1 OVERVIEW
14.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
14.3 ORGANIC GROWTH STRATEGIES
14.3.1 Overview
14.3.2 Product Launch & Approvals
14.3.3 Expansion
14.3.4 Patent and license
14.4 INORGANIC GROWTH STRATEGIES
14.4.1 Overview
14.4.2 Acquisitions
14.4.3 Partnerships, Collaborations & Agreements
14.4.4 Joint Ventures

15. HUMAN MICROBIOME MARKET–KEY COMPANY PROFILES
15.1 ENTEROME
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Financial Overview
15.1.4 Product Portfolio
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MICROBIOME THERAPEUTICS, LLC
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Financial Information
15.2.4 Product Portfolio
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 REBIOTIX INC.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Financial Overview
15.3.4 Product Portfolio
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 YAKULT HONSHA CO., LTD.
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Financial Overview
15.4.4 Product Portfolio
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 OSEL INC.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Financial Overview
15.5.4 Product Portfolio
15.5.5 Swot Analysis
15.5.6 Key Developments
15.6 VEDANTA BIOSCIENCES, INC.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Financial Information
15.6.4 Product Portfolio
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 METABIOMICS CORPORATE
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Financial Overview
15.7.4 Product Portfolio
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 SYNTHETIC BIOLOGICS, INC.
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Financial Information
15.8.4 Product Portfolio
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 DUPONT
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Financial Overview
15.9.4 Product Portfolio
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 BIOMX
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Financial Information
15.10.4 Product Portfolio
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. APPENDIX
16.1 ABOUT THE INSIGHT PARTNERS
16.2 GLOSSARY OF TERMS
16.3 METHODOLOGY
16.3.1 Coverage
16.3.2 Secondary Research
16.3.3 Primary Research

LIST OF TABLES

TABLE 1. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 2. NORTH AMERICAHUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 3. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 4. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 5. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 6. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 7. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 8. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 9. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 10. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 11. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 12. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 13. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 14. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 15. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 16. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 17. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 18. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 19. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 20. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 21. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 22. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 23. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 24. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 25. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 26. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 27. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 28. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 29. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 30. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 31. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 32. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 33. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 34. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 35. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 36. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 37. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 38. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 39. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 40. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN)
TABLE 41. UAE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 42. UAE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 43. UAE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 44. SAUDI ARABIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 45. SAUDI ARABIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 46. SAUDI ARABIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 47. SOUTH AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 48. SOUTH AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 49. SOUTH AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 50. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 51. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 52. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 53. BRAZIL HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)
TABLE 54. BRAZIL HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)
TABLE 55. BRAZIL HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)
TABLE 56. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET
TABLE 57. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET
TABLE 58. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 59. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET
TABLE 60. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET
TABLE 61. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET
TABLE 62. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

FIGURE 1. ASIA PACIFIC HUMAN MICROBIOME MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017
FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION
FIGURE 6. HUMAN MICROBIOME SEGMENTATION, BY REGION
FIGURE 7. NORTH AMERICA PEST ANALYSIS
FIGURE 8. EUROPE PEST ANALYSIS
FIGURE 9. ASIA PACIFIC PEST ANALYSIS
FIGURE 10. MIDDLE EAST AND AFRICA PEST ANALYSIS
FIGURE 11. SOUTH AND CENTRAL AMERICA PEST ANALYSIS
FIGURE 12. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)
FIGURE 16. GLOBAL FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 17. GLOBAL MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 18. GLOBAL PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 19. GLOBAL PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 20. GLOBAL DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 21. GLOBAL DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 22. GLOBAL SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)
FIGURE 24. GLOBAL DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 25. GLOBAL CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 26. GLOBAL AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 27. GLOBAL OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 28. GLOBAL MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 29. GLOBAL OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)
FIGURE 31. GLOBAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 32. GLOBAL THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 33. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 34. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 35. NORTH AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 36. US HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 37. CANADA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 38. MEXICO HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 39. EUROPE HUMAN MICROBIOME MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)
FIGURE 40. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 41. EUROPE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 42. UK HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 43. GERMANY HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 44. FRANCE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 45. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 46. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 47. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 48. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 49. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 50. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 51. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 52. MIDDLE EAST AND AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 53. UAE HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 54. SAUDI ARABIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 55. SOUTH AFRICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 56. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)
FIGURE 57. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 58. SOUTH AND CENTRAL AMERICA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)
FIGURE 59. BRAZIL HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)
FIGURE 60. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 61. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018
FIGURE 62. INORGANIC GROWTH STRATEGIES IN THE ENDOSCOPY DEVICE MARKET, 2015-2018

The List of Companies

 

  1. Enterome
  2. MicroBiome Therapeutics, LLC
  3. Rebiotix Inc.
  4. Yakult Honsha Co., Ltd.
  5. Osel Inc.
  6. Vedanta Biosciences, Inc.
  7. Metabiomics Corporate
  8. Synthetic Biologics, Inc.
  9. DuPont,
  10. BiomX Ltd.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550